{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:19:48Z","timestamp":1792844388601,"version":"4.5.0"},"reference-count":23,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"\n Background & objectives:<\/jats:title>\n Nucleic acid amplification test (NAT) in blood donor screening not only detects window period (WP) donors but also those with chronic occult infections which are negative by routine serological screening. This study was conducted to determine the time trend of NAT positivity and seroprevalence of transfusion-transmitted infections (TTIs) through a period of six years and evaluate the strength of NAT as a supplementary test in identifying the cryptic carriers in blood donor population.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n A total of 1,01,411 blood donations were screened between January 2011 and December 2016 by the ELISA and individual donor (ID) NAT Procleix Ultrio Plus Assay. Additional molecular and serological assays were done on the NAT yield samples to differentiate the type of cryptic carriers.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n NAT yields comprised 0.05 per cent (50\/101411) of the total samples tested with a yield rate of 1\/2028. Hepatitis B virus (HBV) contributed to 80 per cent of the total NAT yields and the rest 20 per cent due to hepatitis C virus (HCV). Majority of HBV NAT yields (75%) were from chronic occult donors and 25 per cent were WP donors. Both HBV and HCV NAT yields had a wide range of viral count. There was no HIV NAT yield. A significant decline in the prevalence rate of TTIs through the study period of six years was observed.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n The cryptic infections found in blood donors increase the risk of TTIs. Blood screening by both serology and NAT can reduce this threat.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1340_17","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T08:11:27Z","timestamp":1561363887000},"page":"389-395","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Nucleic acid amplification test"],"prefix":"10.25259","volume":"149","author":[{"given":"Sanghamitra","family":"Datta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini","family":"Khillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chand","family":"Wattal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-15-20241212","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0973-6247.154250","article-title":"Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety","volume":"9","author":"Kumar","year":"2015","journal-title":"Asian J Transfus Sci"},{"key":"R2-15-20241212","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/0253-7184.203442","article-title":"Seroprevalence of transfusion-transmissible infections among replacement and voluntary blood donors in a tertiary care hospital","volume":"38","author":"Arora","year":"2017","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"R3-15-20241212","doi-asserted-by":"crossref","first-page":"e6126","DOI":"10.5812\/hepatmon.6126","article-title":"Occult hepatitis B (OBH) in clinical settings","volume":"12","author":"Alavian","year":"2012","journal-title":"Hepat Mon"},{"key":"R5-15-20241212","first-page":"907","article-title":"A ten year analysis of multi-drug resistant blood stream infections caused by E. coli & K. pneumoniae in a tertiary care hospital","volume":"135","author":"Datta","year":"2012","journal-title":"Indian J Med Res"},{"key":"R6-15-20241212","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/0971-5916.166598","article-title":"Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in North India","volume":"142","author":"Makroo","year":"2015","journal-title":"Indian J Med Res"},{"key":"R7-15-20241212","first-page":"140","article-title":"Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors","volume":"127","author":"Makroo","year":"2008","journal-title":"Indian J Med Res"},{"key":"R8-15-20241212","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.transci.2013.03.004","article-title":"Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India","volume":"49","author":"Agarwal","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"R9-15-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2893.2009.01245.x","article-title":"Occult hepatitis B virus infection: A covert operation","volume":"17","author":"Hollinger","year":"2010","journal-title":"J Viral Hepat"},{"key":"R10-15-20241212","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2009.05.020","article-title":"Transfusion-transmitted hepatitis B virus infection","volume":"51","author":"Candotti","year":"2009","journal-title":"J Hepatol"},{"key":"R11-15-20241212","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.3748\/wjg.14.5327","article-title":"Anti-HBc screening in Indian blood donors: Still an unresolved issue","volume":"14","author":"Dhawan","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R12-15-20241212","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","article-title":"Statements from the Taormina expert meeting on occult hepatitis B virus infection","volume":"49","author":"Raimondo","year":"2008","journal-title":"J Hepatol"},{"key":"R13-15-20241212","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3748\/wjg.v17.i15.1927","article-title":"An overview of occult hepatitis B virus infection","volume":"17","author":"Said","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R14-15-20241212","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/gutjnl-2011-301281","article-title":"Occult hepatitis B infection in blood donors from South East Asia: Molecular characterisation and potential mechanisms of occurrence","volume":"61","author":"Candotti","year":"2012","journal-title":"Gut"},{"key":"R15-15-20241212","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/jmv.20963","article-title":"HBsAg non reactive HBV infection in blood donors: Transmission and pathogenecity","volume":"79","author":"Gerlich","year":"2007","journal-title":"Med Virol"},{"key":"R16-15-20241212","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejim.2010.12.001","article-title":"Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes","volume":"22","author":"Selim","year":"2011","journal-title":"Eur J Intern Med"},{"key":"R17-15-20241212","first-page":"312","article-title":"Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion","volume":"132","author":"Asim","year":"2010","journal-title":"Indian J Med Res"},{"key":"R18-15-20241212","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1537-2995.2009.02110.x","article-title":"Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa","volume":"49","author":"Vermeulen","year":"2009","journal-title":"Transfusion"},{"key":"R19-15-20241212","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0973-6247.126679","article-title":"Nucleic acid testing-benefits and constraints","volume":"8","author":"Hans","year":"2014","journal-title":"Asian J Transfus Sci"},{"key":"R20-15-20241212","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/0255-0857.148832","article-title":"Utility of routine real time quantitative PCR monitoring of HCV infection in haemodialysis patients","volume":"33","author":"Datta","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"R21-15-20241212","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00005-013-0257-7","article-title":"Seronegative hepatitis C virus infection","volume":"62","author":"Ka\u017amierczak","year":"2014","journal-title":"Arch Immunol Ther Exp (Warsz"},{"key":"R22-15-20241212","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/0973-6247.154252","article-title":"A comprehensive serological and supplemental evaluation of hepatitis B \u201cseroyield\u201d blood donors: A cross-sectional study from a tertiary healthcare center in India","volume":"9","author":"Pandey","year":"2015","journal-title":"Asian J Transfus Sci"},{"key":"R23-15-20241212","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1053\/j.gastro.2008.02.075","article-title":"Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT","volume":"134","author":"Kumar","year":"2008","journal-title":"Gastroenterology"},{"key":"R24-15-20241212","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/1752-1947-6-291","article-title":"Possible transmission of human immunodeficiency virus-1 infection from an Elite controller to a patient who progressed to acquired immunodeficiency syndrome: A case report","volume":"6","author":"Killian","year":"2012","journal-title":"J Med Case Rep"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201949030-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:01:23Z","timestamp":1751497283000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/nucleic-acid-amplification-test-bridging-the-gap-in-blood-safety-re-evaluation-of-blood-screening-for-cryptic-transfusion-transmitted-infection-among-indian-donors\/"}},"subtitle":["Bridging the gap in blood safety & re-evaluation of blood screening for cryptic transfusion-transmitted infection among Indian donors"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1340_17","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}